Maripau Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$251K Sell
987
-55
-5% -$12.8K 0.09% 152
2026
Q1
$255K Buy
+1,042
New +$243K 0.11% 142
2025
Q3
Sell
-2,165
Closed -$331K 150
2025
Q2
$331K Sell
2,165
-527
-20% -$81K 0.17% 110
2025
Q1
$446K Buy
2,692
+843
+46% +$132K 0.26% 85
2024
Q4
$267K Buy
+1,849
New +$287K 0.16% 117
2024
Q3
Sell
-2,062
Closed -$301K 94
2024
Q2
$301K Buy
2,062
+528
+34% +$78.5K 0.21% 98
2024
Q1
$243K Buy
+1,534
New +$244K 0.18% 117
2023
Q4
Sell
-1,331
Closed -$207K 118
2023
Q3
$207K Buy
+1,331
New +$220K 0.19% 92

Other funds holding JNJ

Maripau Wealth Management's JNJ Position: Q2 2026 in Review

Maripau Wealth Management reduced its Johnson & Johnson (JNJ) stake by 5.3% in Q2 2026, selling an estimated $12.8K and leaving 987 shares worth $251K. The position accounts for 0.09% of the portfolio, ranked #152.

Maripau Wealth Management first reported a position in JNJ in Q3 2023 and has held it in 8 quarters since. The position peaked at $446K in Q1 2025. 4,680 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Maripau Wealth Management held 987 shares of Johnson & Johnson worth $251K as of Q2 2026.
  • Maripau Wealth Management sold 55 Johnson & Johnson shares in Q2 2026, an estimated $12.8K.
  • Johnson & Johnson made up 0.09% of Maripau Wealth Management's portfolio in Q2 2026, its #152 holding.
  • Maripau Wealth Management first reported a position in Johnson & Johnson in Q3 2023 and has held it in 8 quarters since.
  • Maripau Wealth Management's Johnson & Johnson position peaked at $446K in Q1 2025.
  • 4,680 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Maripau Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.